Precipio Return on Tangible Equity 2010-2025 | PRPO

Current and historical return on tangible equity values for Precipio (PRPO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Precipio Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.00B $0.00B 0.00%
2024-12-31 $0.00B $0.00B 0.00%
2024-09-30 $0.00B $0.00B -600.00%
2024-06-30 $0.00B $0.00B -600.00%
2024-03-31 $0.00B $0.00B -533.33%
2023-12-31 $-0.01B $0.00B -500.00%
2023-09-30 $-0.01B $0.00B -640.00%
2023-06-30 $-0.01B $0.00B -444.44%
2023-03-31 $-0.01B $0.00B -285.71%
2022-12-31 $-0.01B $0.00B -228.57%
2022-09-30 $-0.01B $0.00B -171.43%
2022-06-30 $-0.01B $0.01B -125.71%
2022-03-31 $-0.01B $0.01B -117.07%
2021-12-31 $-0.01B $0.01B -100.00%
2021-09-30 $-0.01B $0.01B -160.00%
2021-06-30 $-0.01B $0.01B -514.29%
2021-03-31 $-0.01B $0.00B 355.56%
2020-12-31 $-0.01B $0.00B 430.77%
2020-09-30 $-0.02B $0.00B 457.14%
2020-06-30 $-0.02B $0.00B 400.00%
2020-03-31 $-0.02B $-0.01B 475.00%
2019-12-31 $-0.01B $0.00B 280.00%
2019-09-30 $-0.02B $0.00B 226.67%
2019-06-30 $-0.02B $-0.01B 190.00%
2019-03-31 $-0.02B $-0.01B 136.17%
2018-12-31 $-0.02B $-0.01B 163.27%
2018-09-30 $-0.03B $-0.01B 216.67%
2018-06-30 $-0.03B $-0.01B 266.67%
2018-03-31 $-0.04B $-0.01B 298.04%
2017-12-31 $-0.03B $-0.01B 216.39%
2017-09-30 $-0.02B $-0.01B 138.18%
2017-06-30 $-0.01B $-0.02B 59.02%
2017-03-31 $0.00B $-0.02B 0.00%
2016-12-31 $0.00B $-0.01B 20.34%
2016-09-30 $-0.02B $-0.02B 143.28%
2016-06-30 $-0.03B $-0.02B 261.22%
2016-03-31 $-0.04B $-0.02B 388.89%
2015-12-31 $-0.03B $-0.01B 566.67%
2015-09-30 $-0.02B $0.00B 2000.00%
2015-06-30 $-0.01B $0.00B 600.00%
2015-03-31 $-0.01B $-0.01B 577.78%
2014-12-31 $-0.01B $0.01B 933.33%
2014-09-30 $-0.01B $-0.01B 282.35%
2014-06-30 $-0.02B $-0.01B 553.85%
2014-03-31 $-0.02B $0.00B 1700.00%
2013-12-31 $-0.02B $-0.01B -1360.00%
2013-09-30 $-0.02B $0.00B -461.54%
2013-06-30 $-0.01B $0.00B -266.67%
2013-03-31 $-0.01B $0.01B -160.00%
2012-12-31 $-0.01B $0.00B -120.00%
2012-09-30 $-0.01B $0.00B -116.67%
2012-06-30 $-0.01B $0.01B -600.00%
2012-03-31 $-0.01B $0.01B 200.00%
2011-12-31 $-0.01B $0.00B 102.33%
2011-09-30 $-0.01B $-0.02B 102.13%
2011-06-30 $-0.01B $-0.02B 200.00%
2011-03-31 $-0.01B $-0.01B -800.00%
2010-12-31 $0.00B $-0.01B -52.17%
2010-09-30 $0.00B $0.01B -19.51%
2010-06-30 $0.00B $0.01B -9.30%
2010-03-31 $0.00B $0.01B -8.89%
2009-12-31 $0.00B $0.01B -17.39%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.021B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.716B 58.16
Hims & Hers Health (HIMS) United States $11.427B 94.54
Doximity (DOCS) United States $10.997B 48.79
Tempus AI (TEM) United States $10.169B 0.00
IRhythm Technologies (IRTC) United States $5.172B 0.00
Hinge Health (HNGE) United States $4.708B 0.00
Privia Health (PRVA) United States $2.379B 177.36
Inspire Medical Systems (INSP) United States $2.279B 33.50
Enovis (ENOV) United States $1.629B 8.62
Phreesia (PHR) United States $1.597B 0.00
10x Genomics (TXG) United States $1.576B 0.00
Omnicell (OMCL) United States $1.425B 27.46
Schrodinger (SDGR) United States $1.421B 0.00
Azenta (AZTA) United States $1.335B 58.26
Evolent Health (EVH) United States $1.138B 0.00
Clover Health Investments (CLOV) United States $1.125B 0.00
Claritev (CTEV) United States $0.903B 0.00
Fulgent Genetics (FLGT) United States $0.625B 0.00
Veradigm (MDRX) United States $0.514B 0.00
Standard BioTools (LAB) United States $0.490B 0.00
Talkspace (TALK) United States $0.413B 123.50
Zepp Health (ZEPP) Netherlands $0.352B 0.00
Butterfly Network (BFLY) United States $0.350B 0.00
Carlsmed (CARL) $0.322B 0.00
TruBridge (TBRG) United States $0.318B 706.33
Health Catalyst (HCAT) United States $0.257B 0.00
Nyxoah SA (NYXH) Belgium $0.255B 0.00
Outset Medical (OM) United States $0.251B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.216B 0.00
CapsoVision (CV) United States $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.179B 0.00
MDxHealth SA (MDXH) Belgium $0.128B 0.00
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.105B 0.00
CareCloud (CCLD) United States $0.105B 4.75
ImmunoPrecise Antibodies (IPA) Canada $0.085B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.075B 0.00
Pulmonx (LUNG) United States $0.066B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.032B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00